20-21 COVID Info To Know: I Wanna Be Updated!

On this episode of the pod, we return to our discussion on COVID-19. We present updates on the state of COVID-19 with regards to number of cases, hospitalizations, and deaths. We also provide updates on vaccine rollout and the percentage of the population that has been partially and fully vaccinated. We also share some CDC-generated forecasts for next month. We spend some time discussing variants-- in particular the B.1.1.7 variant (also known as the UK variant) which is now the dominant strain in the United States, and how it is shifting the dynamics of viral transmission. We spend some time discussing the increase in cases among children and young adults, and the implications for mitigation measures. We discuss the recent updates released by Pfizer-BioNTech and Moderna on long-term efficacy of the vaccines and, of course, discuss the latest on the Johnson & Johnson vaccine pause. We provide details from the recent ACIP meeting and what we expect to occur in the coming weeks. Finally, we recap some best practices and practical things you can do to continue to protect yourself and others from COVID-19.


PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals.  Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual.  As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional.  If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. 

Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance.

 
As of April 12, national forecasts predict 264,000–850,000 new cases will likely be reported during the week ending May 8. (per the CDC)As of April 12, national forecasts predict 2,500–10,500 new COVID19 deaths will be reported during the week endin…

As of April 12, national forecasts predict 264,000–850,000 new cases will likely be reported during the week ending May 8. (per the CDC)

As of April 12, national forecasts predict 2,500–10,500 new COVID19 deaths will be reported during the week ending May 8. That would bring the projected total number of U.S. deaths to 574,000–598,000.

As of April 12, national forecasts predict 2,500–9,300 newCOVID19 hospitalizations will likely be reported on May 10.

 
28 states around the country are reporting a consistent increase in case numbers. Some of that is driven by variant B.1.1.7 and others

28 states around the country are reporting a consistent increase in case numbers.
Some of that is driven by variant B.1.1.7 and others

ep32.jpg
wave rounded bottom.png
TURKOIS
We are an independent studio - owned by creatives and operated by creatives. We provide the gamut of digital creative services from web and video to graphic and app development. We are the full package to brands and businesses across the industry spectrum - a distilled group of professionals who are bred to build custom cross media projects to the highest expectations.
http://www.turkoisdesign.com/
Previous
Previous

20-21 COVID Info To Know: I Wanna Be Updated! (Part Two)

Next
Next

In the Lyme Light: Beyond The Tick Bite (Part Two)